title: An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.
authors.forename: Meyer Michel
authors.initials: MM
authors.lastname: Samama
authors.forename: Jean
authors.initials: J
authors.lastname: Amiral
authors.forename: Céline
authors.initials: C
authors.lastname: Guinet
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Perzborn
authors.forename: François
authors.initials: F
authors.lastname: Depasse
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects*; D017322:Clinical Trials, Phase II as Topic; D003124:Colorimetry; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring / Q000379:methods*; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000097:blood*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000097:blood*; D019637:Orthopedic Procedures / Q000009:adverse effects; D011237:Predictive Value of Tests; D000069552:Rivaroxaban; D013876:Thiophenes / Q000097:blood*; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control
chemical_list: D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban